BALCX
Price
$33.73
Change
-$0.10 (-0.30%)
Updated
Mar 11 closing price
Net Assets
232.94B
PGPRX
Price
$24.56
Change
-$0.09 (-0.37%)
Updated
Mar 11 closing price
Net Assets
2.06B
Ad is loading...

BALCX vs PGPRX

Header iconBALCX vs PGPRX Comparison
Open Charts BALCX vs PGPRXBanner chart's image
American Funds American Balanced C
Price$33.73
Change-$0.10 (-0.30%)
VolumeN/A
Net Assets232.94B
George Putnam Balanced R
Price$24.56
Change-$0.09 (-0.37%)
VolumeN/A
Net Assets2.06B
BALCX vs PGPRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. PGPRX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and PGPRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 233B vs. PGPRX (2.06B). PGPRX pays higher dividends than BALCX: PGPRX (1.67) vs BALCX (1.26). BALCX was incepted earlier than PGPRX: BALCX (24 years) vs PGPRX (22 years). BALCX (1.32) is less costly to investors than PGPRX (1.18). BALCX is a more actively managed with annual turnover of: 171.00 vs. PGPRX (80.00). PGPRX has a lower initial minimum investment than BALCX: PGPRX (0) vs BALCX (250). PGPRX annual gain was more profitable for investors over the last year : 5.94 vs. BALCX (3.45). PGPRX (38.39) and BALCX (36.55) have equivalent 5 years return.
BALCXPGPRXBALCX / PGPRX
Total Expense Ratio1.321.18112%
Annual Report Gross Expense Ratio1.321.18112%
Fund Existence24 years22 years-
Gain YTD-0.514-1.35538%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets233B2.06B11,327%
Annual Yield % from dividends1.261.6775%
Returns for 1 year3.455.9458%
Returns for 3 years13.5021.5163%
Returns for 5 years36.5538.3995%
Returns for 10 years45.8862.3574%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RCGHX16.56N/A
N/A
Virtus KAR Health Sciences C
OSPAX9.34N/A
N/A
Invesco SteelPath MLP Alpha R6
BLNIX12.63N/A
N/A
Meeder Balanced Institutional
SSGVX123.86N/A
N/A
State Street Glb All Cap Eq ex-US Idx
CZMGX19.40N/A
N/A
Multi-Manager Growth Strategies Inst